Weight Loss Drugs May Fight Addiction: New GLP-1 Drug Study Suggests New research suggests that medications commonly used for weight loss may also help reduce the risk of addiction
What GHK-Cu adds to the formulation: Gene expression modulation across hundreds of genes including collagen genes (Type I, III), tissue inhibitors of metalloproteinases, anti-inflammatory mediators Collagen synthesis stimulation, specifically Type I and Type III collagen the structural proteins of skin, connective tissue, and many other tissues Anti-inflammatory signaling through investigated effects on TNF-, IL-6, and NF-B pathways Copper-peptide chemistry effects including cofactor activity for skin-relevant enzymes Skin-research and hair-research applications (the GHK-Cu literature in these areas is substantial) For the GHK-Cu deep-dive, see Copper Peptides Explained
Who should not take glutathione supplements
GLP-1 medications like semaglutide work by mimicking glucagon-like peptide-1, a hormone that slows stomach emptying, reduces appetite signals in the brain, and improves pancreatic insulin release
proteins), peptides are smaller and easier for your body to absorb